You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0438 Treatment with Abatacept Prevents Experimental Dermal FIBrosis and Induces Regression of Established Fibrosis in a Preclinical Model of Systemic Sclerosis

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Scleroderma, myositis and related syndromes - etiology, pathogenesis and animal models
FRI0438 Treatment with Abatacept Prevents Experimental Dermal FIBrosis and Induces Regression of Established Fibrosis in a Preclinical Model of Systemic Sclerosis

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20151000
Jul 2015600
Aug 2015200
Sep 20152101
Oct 2015401
Nov 2015701
Dec 20151802
Jan 2016700
Feb 2016500
Mar 201632023
Apr 2016700
May 2016900
Jun 20161301
Jul 2016300
Aug 2016400
Sep 20161600
Oct 2016500
Nov 2016500
Dec 2016400
Jan 20171000
Feb 2017700
Mar 2017601
Apr 2017200
May 2017400
Jun 2017100
Jul 2017202
Aug 2017601
Sep 2017401
Oct 2017800
Nov 2017600
Dec 2017400
Jan 2018600
Feb 2018401
Mar 20181200
Apr 2018401
May 20185801
Jun 20181401
Jul 20181000
Aug 2018200
Oct 2018200
Nov 2018801
Dec 2018401
Apr 2019200
May 2019200
Jun 2019400
Jul 2019400
Oct 2019100
Nov 2019901
Dec 2019400
Mar 2020800
Apr 2020200
May 2020800
Jun 2020900
Jul 2020800
Aug 2020400
Sep 20201600
Oct 20201000
Nov 2020600
Dec 2020200
Jan 2021600
Feb 2021200
Mar 2021200
May 2021100
Jun 2021101
Jul 2021100
Sep 2021200
Oct 2021202
Nov 20211400
Dec 2021200
Jan 20221000
Feb 2022400
Mar 2022400
Apr 2022200
May 20221101
Jun 2022400
Jul 20222001
Aug 20222401
Sep 20222001
Oct 2022600
Nov 20221000
Dec 20221200
Jan 20231200
Feb 2023800
Mar 2023400
Apr 2023701
May 20231400
Jun 2023200
Jul 20234001
Aug 2023600
Sep 2023801
Oct 2023200
Nov 20234202
Dec 20231200
Jan 2024400
Feb 2024200
Mar 20241001
Total794054